News|Articles|December 12, 2025
Lipid-Based Formulation in Customized Enteric Capsule for Oral GLP-1 Receptor Agonist Peptide Delivery
Author(s)Lonza Capsugel
Multiple factors affect oral delivery of therapeutic peptides such as acidic and enzymatic degradation in the upper gastrointestinal tract and poor intestinal Permeability.
Related Content
Sponsored Content
Trending on Pharmaceutical Technology
1
What the McKesson-Precision Medicine Deal Signals for Trial Sponsors
2
From Detection to Prediction: Modern Analytical Approaches for Nitrosamine Risk
3
GSK's Jemperli Rectal Cancer Filing Signals Biologics Capacity Shift
4
3D Printing Revolutionizing Tissue Engineering and Regenerative Medicine in Europe
5